Azithromycin News and Research

RSS
Azithromycin, also known as Zithromax, belongs to the class of medicines known as antibacterials orantibiotics. These medicines kill bacteria (small organisms that can cause infection in humans) or stopbacteria from growing. Patients with weakened immune systems, includingpeople with HIV, tend to have more frequent andmore serious bacterial infections. Azithromycinwas approved by the FDA on June 14, 1996, formany uses, including the prevention and treatmentof Mycobacterium avium complex (MAC) inpersons with advanced HIV infection. It is alsobeing investigated to see how well it works inpreventing other kinds of bacterial infections inpeople with HIV.
COVID-19 first wave increased the sale of antibiotic formulations in India

COVID-19 first wave increased the sale of antibiotic formulations in India

Broad-spectrum antibiotic no more effective than placebo in preventing COVID-19 symptoms

Broad-spectrum antibiotic no more effective than placebo in preventing COVID-19 symptoms

What lessons have we learned over a year into the COVID-19 pandemic?

What lessons have we learned over a year into the COVID-19 pandemic?

The great promise of antiviral peptides against SARS-CoV-2

The great promise of antiviral peptides against SARS-CoV-2

Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients

Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients

Are COVID-19 medications safe in pregnancy?

Are COVID-19 medications safe in pregnancy?

Investigators map how drugs were used on people hospitalized with COVID-19  infection

Investigators map how drugs were used on people hospitalized with COVID-19 infection

Ravi Sheth receives 2020 Hertz thesis prize for transforming microbial research

Ravi Sheth receives 2020 Hertz thesis prize for transforming microbial research

Phase 3 trial finds corticosteroid inhaler speeds recovery time in COVID-19 patients

Phase 3 trial finds corticosteroid inhaler speeds recovery time in COVID-19 patients

Hydroxychloroquine has no effect in treating people with COVID-19, study shows

Hydroxychloroquine has no effect in treating people with COVID-19, study shows

Five herbal medicines show potent activity against Babesia duncani in the lab

Five herbal medicines show potent activity against Babesia duncani in the lab

Study calls for continuous monitoring of dark web marketplaces in view of vaccines shortage

Study calls for continuous monitoring of dark web marketplaces in view of vaccines shortage

Ivermectin may not be the ‘silver bullet’ antiviral against COVID-19

Ivermectin may not be the ‘silver bullet’ antiviral against COVID-19

Study shows that single water molecule may cause antibiotic resistance

Study shows that single water molecule may cause antibiotic resistance

Are antibiotic regimens for critical COVID-19 patients with bacterial superinfection unnecessarily high?

Are antibiotic regimens for critical COVID-19 patients with bacterial superinfection unnecessarily high?

Azithromycin trial fails to provide evidence of benefit in COVID-19

Azithromycin trial fails to provide evidence of benefit in COVID-19

Remdesivir likely to be highly effective treatment for COVID-19

Remdesivir likely to be highly effective treatment for COVID-19

Researchers use AI platform to identify best combination of available therapies against COVID-19.

Researchers use AI platform to identify best combination of available therapies against COVID-19.

Using AI to find optimal combination of available therapies against SARS-CoV-2

Using AI to find optimal combination of available therapies against SARS-CoV-2

Chloroquine/hydroxychloroquine could treat COVID-19 infection

Chloroquine/hydroxychloroquine could treat COVID-19 infection